healthcaretrends

Factors driving the growth of the plasma therapy market include rising incidences of trauma and increasing healthcare expenditure worldwide. The report provides a detailed overview of drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the plasma therapy industry, along with estimates and forecast of the revenue and market share analysis.

The global plasma therapy market is expected to grow from USD 135.6 Million in 2016 to USD 297.6 Million by 2021, at a CAGR of 14.0%.

Get More Crucial Insights: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186196333

Application of Plasma Therapy Market:

On the basis of application, the plasma therapy industry is segmented into dermatology, cardiac muscle injury, dental, nerve injury, and others. The orthopedic segment is further categorized into arthritis, chronic tendinitis, and bone repair & regeneration. Similarly, the dermatology segment is classified into androgenic alopecia and plastic surgery. Among all applications, the dermatology segment is expected to grow at a high CAGR from 2016 to 2021, owing to increase in the adoption of cosmetic procedures and prevalence of dermatological disorders such as androgenic alopecia.

Pure PRP Plasma Therapy:

The pure PRP segment is estimated to account for the largest share of the global plasma therapy market in 2016. This segment is projected to grow at the highest CAGR from 2016 to 2021. The high growth of the pure PRP segment can be attributed to its high success rate and its antimicrobial effects.

Autologous Plasma Therapy:

The autologous segment is estimated to account for the largest share of the global plasma therapy market in 2016, owing to its safety and effective results. Prevalence of orthopedic disorders such as arthritis and tendinitis has propelled the demand for advanced treatment options. This has further contributed to the growth of the plasma therapy industry.

Plasma Therapy Market Growth in Hospitals and Clinics:

With respect to end user, the plasma therapy industry is segmented into hospitals & clinics and research institutes. The hospitals & clinics segment is estimated to account for the largest share of the global plasma therapy in 2016. Rise in healthcare spending has resulted in the increasing use of platelet-rich plasma therapy (PRP) in hospitals & clinics.

Get Expert Analysis and Insights of Global Market | Download Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=186196333

Geographical Growth Analysis of Plasma Therapy Market:

The global plasma therapy industry is segmented into North America, Europe, Asia-Pacific, and rest of the world (RoW). North America is estimated to account for the largest share of the global plasma therapy industry in 2016. This large share is mainly attributed to the increase in aging population and initiatives undertaken by the government to support developments in the field of plasma therapy.

Key Market Players:

Key players in the global plasma therapy industry include BioLife Plasma Services (U.S.), Cambryn Biologics LLC (U.S.), Biotest (Germany), CSL Ltd. (Australia), Grifols International S.A. (Spain), Kedrion S.p.A. (Italy), LFB S.A. (France), Bio Products Laboratory Ltd. (BPL) (U.K.), China Biologic Products, Inc. (China), and Octapharma (Switzerland). 

Growth in the mass spectrometry market is primarily driven by factors such as government initiatives for pollution control and environmental testing, increasing spending on pharmaceutical R&D across the globe, government regulations on drug safety, growing focus on the quality of food products, increase in crude and shale gas production, and technological advancements in mass spectrometers.

The mass spectrometry market is expected to grow from $4.6 billion in 2019 to $6.3 billion by 2024, at a CAGR of 6.7%.

Get More Crucial Insights of Market: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=437

Pharmaceutical & biotechnology are the primary application areas of the global mass spectrometry market:

Mass spectrometry is widely used for accurate analysis of small as well as large molecules in pharmaceuticals, forensic & clinical research, and other areas.

The market is segmented into pharmaceutical & biotechnology applications, environmental testing, food & beverage testing, petrochemical applications, and other applications based on use. The pharmaceutical & biotechnology applications segment estimated to command the largest share of the market in 2019, and this segment is also projected to register the highest CAGR owing to the rise in pharmaceutical biosimilars phytopharmaceuticals and regenerative medicine along with the growing research in proteomics and metabolomics.

The Hybrid Mass Spectrometry:

The hybrid mass spectrometry segment is expected to witness the fastest growth during the forecast period. Advantages offered by hybrid mass spectrometers, such as rapid and high-resolution testing abilities with more accurate and precise results, are increasing its adoption. Consequently, the demand for mass spectrometry devices for high throughput screening is also growing.

North America and APAC to Dominate The Global Mass Spectrometry Market:

North America held the largest share of the market in 2018 and is projected to continue to do so during the forecast period. Factors such as the growing funding for research and government initiatives in the US, widespread usage of mass spectrometry in the metabolomics and petroleum sector, and CFI funding towards mass spectrometry projects in Canada are driving the North American market.

While North America is expected to dominate the global mass spectrometry market in 2019, the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the numerous expansions and collaborations by key players in China, a significant amount of funding for mass spectrometry in Japan, and strict environmental monitoring regulations in India.

Get Expert Analysis and Insights of Global Market | Download Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=437

Key Questions Answered in This Report:

1. Which of the platform segments will dominate the mass spectrometry market in the next five years?
2. What are the upcoming technologies in the market?
3. Which application segment will dominate the market in the next five years?
4. Emerging countries have immense opportunities for the growth and adoption of mass spectrometry, will this scenario continue in the next five years?

Key Players:

The major players operating in the mass spectrometry market include SCIEX (US), Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), and Shimadzu Corporation (Japan). The other players in this market include PerkinElmer (US), Bruker (US), Analytik Jena (Germany), JEOL (Japan), Rigaku (Japan), DANI Instruments (Italy), LECO (US), Hiden Analytical (UK), Kore Technology (UK), Extrel CMS (US), MassTech (US), AMETEK Process Instruments (US), MKS Instruments (US), Advion (US), and FLIR Systems (US).

The growth of a interventional oncology market is primarily driven by the rising preference for minimally invasive procedures, expansion of the target patient population, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and increasing government investments and funding for interventional oncology and related cancer research.

Market Growth Analysis:
The global Interventional Oncology Market is projected to reach $2.9 billion in coming years.

To Gain Crucial Insights Into the Market | Download PDF Brochure Now:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164

Ablation Devices Segment Growing at a Highest Rate:

The interventional oncology industry is segmented into ablation devices, embolization devices, and support devices. The embolization devices segment accounted for the largest share of the interventional oncology market in 2018. The large share of this segment can be attributed to the rising prevalence of cancer, product enhancements, and the increasing adoption of Yttrium-90 radioembolic agents in emerging countries.

Transcatheter Arterial Chemoembolization (TACE) and Selective Internal Radiation Therapy (SIRT):

the global interventional oncology industry is segmented into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE) or selective internal radiation therapy (SIRT), and transcatheter arterial embolization (TAE) or bland embolization. In 2018, the TARE/SIRT procedures segment accounted for the largest market share majorly due to the rising prevalence of cancer, increasing demand for minimally invasive procedures, growing adoption of embolization procedures, and the clinical efficacy of Yttrium-90 radioembolic agents (which are used in these procedures).

The Liver Cancer Segment Accounted For The Largest Share Of The Interventional Oncology Market:

The interventional oncology market is segmented into liver cancer, kidney cancer, lung cancer, bone cancer, and other cancers (includes pediatric cancer, prostate cancer, and breast cancer). The liver cancer segment accounted for the largest share of the interventional oncology market in 2018. The large share of this segment can be attributed to factors such as rising cases of liver cancer across the globe and growing initiatives/research activities for developing advanced liver cancer therapies using interventional oncology.

Geographical Growth Analysis:

The Asia Pacific regional market is expected to grow at the highest CAGR during the forecast period. Emerging economies in the region such as India, China, and South Korea, along with developed markets such as Japan and Australia, are offering high-growth opportunities for market players in the field of interventional oncology. This can be attributed to factors such as the increasing adoption of interventional oncology procedures, growing incidence of cancer, and the growing geriatric population.

Get Expert Analysis and Insights of Global Market | Download Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=203687164

Key Market Players:

The major players operating in the interventional oncology market include BTG plc (UK), Medtronic (Ireland), Boston Scientific (US), Terumo (Japan), Merit Medical (US), Sirtex (China), AngioDynamics (US), Ethicon (US), Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves Medical (US), Sanarus (US), IMBiotechnologies (Canada), Trod Medical (US), IceCure Medical (Israel), Mermaid Medicals (Denmark), Interface Biomaterials BV (Netherlands), Guerbet (France), ABK Biomedical (Canada), Shape Memory Medical (US), Endo Shape (US), Monteris Medical (US), Instylla (US), and Trisalus Lifesciences (US), among others.

Factors such as the implementation of government initiatives to increase EHR adoption, growing adoption of data-driven decision-making, growing pressure to curb healthcare spending and improve patient outcomes, big data in healthcare, and the increasing number of patient registries are expected to drive the growth of the healthcare business intelligence market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252368925

Vendors are increasingly delivering BI platforms with high levels of internal platform integration and embedded BI capabilities which is driving the growth of this segment

On the basis of component, the healthcare BI market is segmented into platforms, software, and services. In 2018, the healthcare business intelligence platforms segment are expected to account for the largest share of the market. The large share of this market segment is mainly driven by the increasing requirement for customized BI solutions catering to individual requirements of organizations and allowing them the flexibility to build and integrate BI solutions into existing healthcare business applications for higher efficiency and reduced costs.

OLAP & visualization is expected to account for the largest share of the healthcare business intelligence market in 2018

The market, by function, is segmented into OLAP & visualization, performance management, and query & reporting. In 2018, OLAP & visualization is expected to account for the largest share of the market. OLAP & visualization provides quick insights for decision-making, allows for productivity improvement, and provides competitive advantages; these benefits have supported the growth of this market segment.

The increasingly focusing on cutting costs and implementing practices that will help their operations remain profitable has made financial analysis solutions all the more significant

Based on application, the healthcare business intelligence market is segmented into clinical analysis, financial analysis, and operational analysis. In 2018, financial analysis segment are expected to account for the largest share of the market. Due to the rising focus of payers on the early detection of fraud and reducing preventable costs, the market for financial analysis is expected to register a significant growth during the forecast period.

Get Expert Analysis and Insights of Global Market | Request Sample Report:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=252368925

North America is expected to account for the largest market size during the forecast period

The market is dominated by North America, followed by Europe, Asia, and RoW. The market in North America is expected to witness the highest growth during the forecast period. The high growth of the North American market can be attributed to the increasing adoption of healthcare intelligence solutions and services by healthcare providers (especially in the US) to provide better quality care and lower healthcare costs is a major factor driving market growth.

Key players in healthcare business intelligence market

The market is highly competitive in nature, with several big as well as emerging players. Prominent players in this market include Microsoft (US), IBM (US), Oracle (US), SAP SE (Germany), SAS Institute Inc. (US), Tableau Software (US), MicroStrategy Incorporated (US), QlikTech International AB (US), Information Builders (US), Sisense Inc. (US), Yellowfin BI (Australia), and BOARD International (Switzerland).

How The Global Digital Diabetes Management Market to Revolutionize the Global Healthcare Industry.

The growth of this market is mainly driven by the rising prevalence of diabetes, increasing focus on the development and adoption of digital platform for diabetes, and technological advancements.

The Digital Diabetes Management Industry to Offer $19.9 billion Growth Globally.
Know more, Download PDF Brochure Now:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144725893

The wearable devices segment is expected to account for the largest share of the digital diabetes management market:

The large share of the market is mainly due to factors such as the increasing number of regulatory approvals for CGM systems; technological advancements such as closed-loop pump systems, smart insulin patches, and other pipeline devices; and the growing adoption of smart insulin pumps and insulin patches for self-insulin delivery in diabetes management.

The self/home healthcare segment accounted for the largest share of the digital diabetes management market:

The large share of this segment can mainly be attributed to technological advancements and a shift toward home care and self-management of diabetes.

North America is expected to grow at the highest CAGR during the forecast period

The global digital diabetes management market in North America is expected to grow at the highest CAGR during the forecast period. This is due to the growing demand for technologically advanced solutions such as closed-loop systems, high adoption of remote online coaching services for diabetes management, high adoption of connected diabetes management devices and apps, favorable reimbursement policies, increased acceptance of digital diabetes solutions from payers, rising awareness on self-diabetes management and government initiatives to promote digital health in the region.

Get Expert Analysis and Insights of Global Market | Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=144725893

Medtronic is the leading provider of digital diabetes management solutions across the globe. The company offers a portfolio of health information exchange solutions, clinical decision support solutions, and telehealth solutions and services to meet the needs of patients and physicians working in the areas of diabetes management. The company focuses on developing integrated devices that enable data sharing between devices, patients, care providers, and healthcare professionals to help generate actionable insights.

Roche is one of the leading providers of blood glucose monitoring systems in the digital diabetes management market. The company offers digital glucometers, diabetes management applications, and data management software. To maintain its position in this market, the company focuses on expanding its product portfolio through organic and inorganic strategies, such as product launches, collaborations, partnerships, agreements, and acquisitions. For instance, in 2017, the company acquired mySugr GmbH, which helped it to expand its product portfolio in the area of diabetes management apps. Also, in 2018, Roche partnered with various companies such as Wellthy Therapeutics Private Limited (India), Ieso Digital Health Ltd. (UK), and Care Innovations Ltd. (US) to integrate its existing portfolio and develop solutions for global, personalized management of diabetes by connecting patients and healthcare professionals to better control the disease.

The rising applications of Q TOF mass spectrometers in pharmaceuticals and biotechnological industries, coupled with the increasing R&D activities in these sectors, would result in high adoption of this technology. In addition, favorable government initiatives and increased focus on producing high-quality products are the major factors that contribute to the
Q-TOF Mass Spectrometry Market growth.

The availability of government funding for various research projects in a number of countries such as the US and Canada will open new opportunities for market players. In the US, the National Institute of Health (NIH) has provided a grant of USD 694 million for Environmental Health Sciences (NIEHS) and USD 344 million for Biomedical Imaging/Bioengineering (NIBIB). In March 2016, the Minister of State for Science and Technology announced an investment of USD 23 million for supporting 95 research projects at 26 universities across Canada.

The global Q TOF mass spectrometry market was valued at USD 651.5 million in 2016 and projected to reach USD 1,009.7 million by 2022, grow at a CAGR of 7.7%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173939840

The report analyzes the market by application and region. On the basis of application, the Q TOF mass spectrometry market has been segmented into biotech applications, pharmaceutical applications, food and beverage testing, environmental testing, petrochemical applications, and other applications. In 2017, biotech applications are expected to account for the largest share of the market and this segment is also projected to register the highest CAGR during the forecast period.

Geographically, North America is estimated to account for the largest share of the global Q TOF mass spectrometry industry, followed by Europe. The growing government funding and increasing biotech and biopharma R&D in the US are the major factors driving the growth of the North American market. The increasing funding for R&D in Canada is expected to propel the market growth during the forecast period. However, the high costs of Q-TOF mass spectrometry instruments is restraining the growth of this market at present.

As of 2017, the global market was dominated by Waters Corporation (US), Agilent Technologies (US), and SCIEX (Subsidiary of Danaher) (US). These companies accounted for a majority share of the global Q TOF mass spectrometry market in 2017. Other players involved in this market include Bruker (US), and Shimadzu Corporation (Japan).

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=173939840

Target Audience:

1. Mass spectrometry and related device manufacturing companies
2. Suppliers and distributors of mass spectrometry systems
3. Research institutes and academic centers
4. Pharmaceutical and biopharmaceutical companies
5. Biotechnology companies
6. Environment protection agencies and institutes
7. Food, beverage, and agricultural analyses companies
8. Cosmetic companies

The endoscopes segment dominated the Endoscopy Equipment Market:

Endoscopes accounted for the largest share of the market in 2018, and this segment is also estimated to grow at the highest CAGR during the forecast period. The dominant market share and growth rate of this segment can be attributed primarily to the rising adoption of minimally invasive procedures, increasing technological advancements, and the use of disposable endoscopes.

GI endoscopy accounted for the largest share of the Endoscopy Equipment Market:

The GI endoscopy applications segment is expected to command the largest share of the market and grow at the highest CAGR during the forecast period. Rising geriatric population, improving healthcare infrastructure in developing countries, and an increasing number of colonoscopy procedures performed in developed countries, are some factors supporting the growth of this applications segment. 

Get More Information | Download PDF Brochure Now:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=689

Hospitals accounted for the largest share of the Endoscopy Equipment Market:

The hospital segment is expected to register the highest CAGR during the forecast period. This can be attributed to increasing government and private funding and the growing preference among physicians and patients to perform endoscopic procedures in a hospital-based environment.

North America to Offer Business Expansion and Investment Opportunities in Endoscopy Equipment Market:

The large share of North America in the global endoscopy devices market is attributed to the favorable reimbursement scenario in the US, rising incidence of cancer, increasing investments by hospitals to purchase new endoscopic equipment, and increasing research activities to improve endoscopy and the implementation of a new funding model for Canadian hospitals.

The major players in this market include Olympus (Japan), KARL STORZ (Germany), Stryker (US), Boston Scientific (US), Ethicon (US), Fujifilm Corporation (Japan), Medtronic (Ireland), Hoya Corporation (Japan), Richard Wolf GmbH (Germany), Smith & Nephew (UK), Cook Medical (US), and B. Braun (Germany).

Get Expert Analysis and Insights of Global Market | Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=689

Recent Development In Global Endoscopy Equipment Market:

1. Olympus launched small intestine endoscopy system “PowerSpiral” in Europe and parts of Asia, including Hong Kong and India

2. Olympus launched ENF-VT3, the world’s first rhino-laryngo videoscope to incorporate 4-direction angulation capability.

3. KarlStroz launched 4 mm Endoscopic NIR/ICG Fluorescence Imaging System to enhance minimally invasive neurosurgery

The growth of this market is driven majorly by factors such as growing demand for endoscopy, growing investments, funds, and grants, rising number of hospitals and increasing hospital investments in endoscopy facilities, and technological advancements.

What are the Global Growth Factors?

Factors such as increasing number of minimally invasive surgeries, technological advancements in fluid management system, and increase in government funds and grants worldwide for endosurgical procedures are driving the Fluid Management Systems Market.

What The Experts Says about the Market Growth?

The fluid management systems and accessories market is projected to reach $12.47 Billion by 2021 from USD 9.39 Billion in 2016, at a CAGR of 5.8%.

Browse and in-depth TOC on "Fluid Management Systems Market"

121 – Tables
36 - Figures
208 - Pages

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153551158

Based on the product type, the fluid management systems and accessories is segmented into fluid management systems and fluid management disposables & accessories. In 2015, the fluid management systems accounted the largest share of the market. The large share of this segment is mainly attributed to rising number of minimally invasive surgeries and high adoption of these systems in hospitals.

Furthermore, the fluid management systems segment is sub-divided into integrated fluid management systems and standalone fluid management systems. The standalone systems accounted the largest share of fluid management systems in 2015. The large share of this segment is mainly attributed to the increase in geriatric population, increase in the number of end-stage kidney patients and high adoption of these systems in hospitals over integrated fluid management systems. Among application segments, urology accounted the largest share while, laparoscopy is growing with the highest CAGR.

Geographical Analysis:

North America was the major market for fluid management systems and accessories followed by Europe and Asia-Pacific. The large share of this region can be attributed to the growth in aging and chronically ill population, increasing number of minimally invasive surgeries, growth in the number of dialysis centers, rising usage of single-use disposable accessories, and advancements in technologies. The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.

Get Expert Analysis and Insights of Global Market | Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=153551158

Key Market Players:

Some of the major players operating in the fluid management systems and accessories market include Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (U.S.), B. Braun Melsungen AG (Germany),  Stryker Corporation (U.S.), Olympus Corporation (Japan), Ecolab Inc. (U.S.), Cardinal Health, Inc. (U.S.), Smiths Medical (U.K.), KARL STORZ GmbH & Co. KG (Germany), Zimmer Biomet Holdings Inc. (U.S.), AngioDynamics, Inc. (U.S.), and Karl Storz GmbH & Co. KG (Germany).

According to a new market research report "Hydrophobic Interaction Chromatography Market by Product & Services (Resin, Columns (Empty, Prepacked), Buffer), Sample (Monoclonal Antibodies, Vaccines), End User (Pharmaceutical Companies, CROs & CMOs, Research Institutes) - Global Forecast to 2023", published by MarketsandMarkets™, the global market is projected to reach USD 418.2 million in 2023 from USD 291.3 million in 2018, at a CAGR of 7.5%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200633435

The increasing demand for monoclonal antibodies and increasing R&D expenditure in biopharmaceuticals are the major factors driving the growth of the market.

Browse 83 market data Tables and 27 Figures spread through 112 Pages and in-depth TOC on "Hydrophobic Interaction Chromatography Market".

Based on product and service, the products segment to account for the largest share of the market in 2018
In 2018, the products segment is expected to account for the largest share of the global Hydrophobic Interaction Chromatography Market. This segment is also expected to grow at the highest CAGR during the forecast period. The large share and high growth can be attributed to the increasing demand for membrane-based resins and the growing requirement of ready-to-use prepacked columns in purification processes.

Based on sample type, the monoclonal antibodies segment is expected to grow at the highest CAGR during the forecast period
On the basis of sample type, the global Hydrophobic Interaction Chromatography Market is divided into monoclonal antibodies, vaccines, and other samples. The monoclonal antibodies segment is expected to grow at the highest CAGR during the study period. This can be attributed to the increasing application of mAbs in autoimmune disorders, CVD, infectious diseases, and cancer.

Asia Pacific is expected to grow at the highest CAGR during the forecast period 
The APAC region is expected to grow at the highest CAGR over the next five years. This growth is primarily driven by the increased research and development activities in countries such as China and India and increasing number of CROs, CMOs, and research institutes in these emerging economies.

Get Expert Analysis and Insights of Global Market | Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=200633435

Market Players 
The key players in the global Hydrophobic Interaction Chromatography Market are GE Healthcare (US), Bio-Rad Laboratories (US), Sartorius (Germany), and Thermo Fisher Scientific (US).

The major factors driving the growth of this market are rising incidence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries. However, new players in the interventional radiology products market face significant entry barriers; this is a key challenge in the market.

According to a new market research report "Interventional Radiology Products Market by type (Stents, Catheters, IVC Filter, Accessories), Procedure Type (Angioplasty, Angiography, Biopsy, Thrombolysis, Embolization), Applications (Oncology, Cardiology, Urology & Nephrology) - Forecast to 2021", published by MarketsandMarkets.

The global market is expected to reach USD 8.02 Billion by 2021 from USD 6.35 Billion in 2016, at a CAGR of 4.8% from 2016 to 2021.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=67681703

Key players in the interventional radiology products market include Abbott Vascular (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), Cardinal Health (U.S.), B. Braun Melsungen AG (Germany), C.R Bard (U.S.), Biosensor International Group Ltd. (Singapore), Stryker Corporation (U.S.), Terumo Corporation (Japan), and Cook Medical Inc. (U.S.).

Based on type, the market is segmented into stents, catheters, IVC filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy systems, embolization devices, biopsy needles, and accessories. In 2016, the stents segment is expected to dominate the global interventional radiology products industry. The key factors driving the growth of the interventional radiology stents market are the growing geriatric population and increasing incidence of cardiovascular diseases around the world.

Browse and in-depth TOC on "Interventional Radiology Products Market”
79 – Tables
37 - Figures
144 - Pages

Based on procedure, the market is segmented into angioplasty, angiography, embolization, thrombolysis, biopsy & drainage, vertebroplasty, nephrostomy, and other applications. In 2016, the angiography segment is expected to account for the largest share of this market. The growing demand for minimally invasive procedures and rising geriatric population are the key factors driving market growth in this segment.

Get Expert Analysis and Insights of Global Market | Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=67681703

Based on region, the global interventional radiology products market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the market. The rising incidence of chronic diseases (CVD), the increasing demand for minimally invasive procedures, and availability of reimbursement for minimally invasive products in this region are the major factors contributing to the growth of this market.

What is the future growth analysis of global Oligonucleotide Synthesis Market?

The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7%

What are key factors driving growth of global Oligonucleotide Synthesis Market?

This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.

What the growth opportunities are in Oligonucleotide Synthesis Market?

1. Untapped Emerging Markets
2. Increasing Use of Synthesized Oligos in Molecular Diagnostics 
3. Rise in Venture Capital Investments

Know more, Download PDF Brochure Now:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350

Global Market Segmentation:

In the current market scenario, there is a growing demand for Oligonucleotide Synthesis. The market has been categorized based on the product, type, application, and region.

The synthesized oligos market, by product, is segmented into oligonucleotide-based drugs, primers, probes, large-scale synthesized oligos, intermediate-scale synthesized oligos, and linkers and adaptors. Of these, oligonucleotide-based accounted for over 50% of the synthesized oligos market share in 2018. This segment is also estimated to grow at the highest CAGR during the forecast period due to the increasing demand for oligonucleotide-based drugs and the influx of new customers in the oligo drug development arena.

Based on end user, the oligonucleotide synthesis market is segmented into academic research institutes, diagnostic laboratories, pharmaceutical & biotechnology companies, and hospitals. Hospitals contributed to the highest revenue generated among these segments within the market in 2018. The significant number of inpatient and outpatient visits in hospitals coupled with the high requirement of oligonucleotide drugs to cater to the demand from the vast patient pool suffering from diseases such as Duchenne muscular dystrophy, spinal muscular atrophy, and hepatic veno-occlusive disease, is driving the market growth in the segment.

Geographic Growth Analysis:

The global oligonucleotide synthesis industry is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America was the largest market for share, followed by Europe. Moreover, North America is estimated to register the highest CAGR during the forecast period primarily due to the increasing R&D activities and the growing number of oligonucleotide-based drugs/therapies being approved by the FDA.

Get Expert Analysis and Insights of Global Market | Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=200829350

Key Players In Global Oligonucleotide Synthesis Market:

The prominent players operating in oligonucleotide synthesis market include Agilent Technologies, Inc. (US), ATDBio Ltd. (UK), Bio-Synthesis, Inc. (US), BioAutomation Corporation (US), LGC Biosearch Technologies (US), Biogen International (US), Sarepta Therapeutics (US), Eurofins Genomics (Germany), Eurogentec (Belgium), GeneDesign, Inc. (Japan), GE Healthcare (US), GenScript, Inc. (US), Integrated DNA Technologies (IDT, US), Nitto Denko Avecia, Inc. (US), Sarepta Therapeutics (US), Thermo Fisher Scientific, Inc. (US), TriLink BioTechnologies (US), and Sigma-Aldrich Corporation (US) (a part of Merck KGAA).

Sigma-Aldrich Corporation (US) was one of the leading players in the oligonucleotide synthesis market in 2018. The company is innovation-centric and focuses on R&D to develop and introduce new enhanced products in the market. It is a leading supplier of custom DNA and RNA oligonucleotides for the life sciences research community in North America. Thermo Fisher Scientific is another leading player in the market. The company’s strong brand recognition and extensive product portfolio in this market are its key strengths. To maintain its leading position in the market, the company adopts organic as well as inorganic growth strategies such as expansions and acquisitions.

The global trace metal analysis market is projected to reach USD 6.9 billion by 2024 from USD 4.4 billion in 2019, at a CAGR of 9.5%. The growth of this market is mainly driven by the stringent safety and quality regulations and new international cGMP & cGDP certification for pharmaceutical excipients, increasing spending on life science R&D, advancements in technologies, growing preference to outsource analytical requirements to third-party service providers, increasing demand from applied markets, rising opportunities in emerging countries, and the need to comply with revised USP guidelines.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=83951074

Prominent players in the global trace metal analysis industry are Agilent Technologies (US), Thermo Fisher Scientific (US), PerkinElmer, Inc. (US), Analytik Jena AG (Germany), Bruker Corporation (US), Hitachi Hi-Technologies Corporation (Japan), Rigaku Corporation (Japan), Shimadzu Corporation (Japan), Eurofins Scientific (Luxembourg), Intertek Group PLC (US), SGS S.A. (Switzerland), Bureau Veritas S.A. (France), TÜV SÜD (Germany), and LGC Ltd. (UK).

The trace metal analysis market in APAC is expected to grow at the highest CAGR during the forecast period. This is due to the growing use of trace metal analysis in the food industry, strategic expansion by market players in the Asia Pacific region, emerging biotech industry, increasing focus on soil testing, and the growing food safety and environmental safety concerns in several Asia Pacific countries. The increasing R&D funding, a growing number of CROs, and favorable government initiatives to promote the growth of pharmaceutical and biotechnology industries are some of the other major factors driving the growth of the Asia Pacific market.

Premium Insights of Trace Metal Analysis Market:

1. Trace Metal Analysis Industry Overview
2. Asia Pacific: Trace Metal Analysis Industry, By Application and Country, 2018
3. Geographic Snapshot of the Trace Metal Analysis Industry
4. Geographic Mix: Trace Metal Analysis Industry
5. Trace Metal Analysis Industry: Developing vs Developed Markets

Trace Metal Analysis Market Drivers:

1. Stringent Safety and Quality Regulations
2. Technological Advancements
3. Increasing Demand From Applied Markets
4. Rising Life Science R&D Expenditure

Trace Metal Analysis Market Opportunities:

1. Growing Preference to Outsource Analytical Requirements to Third-Party Service Providers
2. Emerging Countries
3. Need to Comply With Revised USP Guidelines

Agilent is the leading provider of trace metal analysis solutions across the globe. The company offers an extensive product portfolio of products and software for all the trace metal analysis technologies such as ICP-MS, ICP-OES, and AAS. The company focuses on developing technologies that enable in detecting trace metal from various samples for various industries in order to serve the customer base.

Get Expert Analysis and Insights of Global Market | Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=83951074

Thermo Fisher Scientific is a leading provider of superior quality analytical instruments, software, and services for trace metal analysis. The company continuously increases its depth of capabilities in technologies, software & services, and leverages its extensive global channels to address its customers’ emerging needs. The company focuses on R&D to maintain its leading position in this market. Also, in the past three years, Thermo Fisher Scientific launched and enhanced 15 products with innovative technologies.

Applications of Trace Metal Analysis Market:

1. Environmental Testing
2. Food & Beverage Testing
3. Pharmaceutical & Biotechnology Products Testing
4. Oil & Gas Testing
5. Medical Device Testing
6. Semiconductor Testing
7. Clinical Diagnostics

The enteral feeding devices market is projected to reach USD 4.1 billion by 2024 from USD 2.9 billion in 2019, at a CAGR of 6.7%. Growth in this market is driven by the rising healthcare costs, surge in the number of preterm births, growth in the aging population, rising prevalence of chronic diseases, growing awareness of enteral nutrition, and improvements in healthcare facilities in emerging countries.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035

Enteral nutrition is more physiological, with fewer complications as compared to parenteral nutrition. The major advantage of enteral nutrition is the maintenance of the GI mucosal barrier, stimulating intestinal blood flow. Enteral administration also helps in maintaining small intestine mass and pancreatic functions, improves healing & recovery, reduces muscle catabolism, and lowers the risk of infection and contamination. According to an article published in the German Medical Science journal, major septic complications affect only 3% of patients on enteral nutrition as compared to over 20% of those on parenteral nutrition.

Recent Developments in Enteral Feeding Devices Market:

1. In June 2018, Fresenius Kabi invested USD 11 million (EUR 9 million) to expand its production facility in the UK with a new distribution and operations center, scheduled to open in 2019.

2. In December 2018, Nestlé Health Science opened the new Nestlé Product Technology Center in New Jersey with an investment of USD 70 million.

3. In April 2018, B. Braun opened five new production plants and administrative buildings in Penang, Malaysia.

4. In May 2017, Avanos Medical Inc. (US) launched the Halyard Enteral Drainage System, a closed system for the drainage and collection of gastrointestinal tract contents from patients using an enteral device.

Premium Insights of Enteral Feeding Devices Market:

1. Enteral Feeding Devices Market Overview
2. Asia Pacific: Market, By Type
3. Geographic Growth Opportunities
4. Market, By Region (2017–2024)
5. Developed Vs. Developing Markets

Global Enteral Feeding Devices Market Drivers:

1. Shift From Parenteral to Enteral Nutrition
2. Increasing Incidence of Preterm Births
3. Growing Demand for Enteral Feeding in the Home Care Sector
4. Increasing Prevalence of Chronic Diseases

Enteral Feeding Devices Market Restraints:

1. Complications Associated With Enteral Feeding Devices

Enteral Feeding Devices Market Opportunities:

1. High Growth Opportunities in Emerging Countries

Market Challenges:

1. Insufficient Reimbursement for Enteral Nutrition
2. Dearth of Skilled Professionals

Get Expert Analysis and Insights of Global Market | Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=183623035

Critical Questions Answered in Research Report:

1. How will current technological trends affect the market in the long term?

2. What are the current growth trends in the market for pediatrics?

3. What are the application areas of the market?

4. Which regions are likely to grow at the highest CAGR?

5. What are the growth strategies being implemented by major market players?

Key Players of Enteral Feeding Devices Market:

The prominent players in this market are Fresenius Kabi AG (Germany), Avanos Medical, Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Abbott Laboratories (US), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Medical, Inc. (US), CONMED Corporation (CONMED) (US), Nestlé S.A. (Switzerland), Danone (France), Moog, Inc. (US), Vygon (France), Amsino International (US), and Applied Medical Technology, Inc. (US).

The blood group typing market is projected to reach USD 3.12 Billion by 2021 from USD 1.95 Billion in 2016, at a CAGR of 9.8%. The increasing demand for blood and blood products, growing number of road accidents and trauma cases that necessitate blood transfusion, need for blood grouping during prenatal testing, and increasing usage of blood group typing in forensic sciences are the major factors fueling the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72074095

The market is segmented based on product & service, technique, test type, end user, and region.

The market is segmented into four major regions North America, Europe, Asia, and the Rest of the World. In 2016, North America accounted for the largest share of the market, followed by Europe. North America will continue to dominate the market in the forecast period due to the availability of reimbursement for several surgeries and increasing prevalence of chronic disorders in the region. However, the market in Asia is expected to witness the highest CAGR, with the growth centered on China, Japan, and India.

Premium Insights of Blood Group Typing Industry:

1. Blood Group Typing: Market Overview
2. Geographic Analysis: Blood Group Typing Market, By End User
3. Geographical Snapshot of the Market
4. Blood Group Typing Industry Size, By Technique, 2016 vs 2021

Key Factors Driving Growth In Blood Group Typing Market:

1. Increasing Number of Blood Donations
2. Growing Number of Road Accidents, Emergencies, and Trauma Cases Necessitating Blood Transfusions
3. Increasing Demand for Blood Group Typing in Prenatal Testing
4. Increasing Usage of Blood Group Typing in Forensic Sciences
5. Stringent Regulatory Standards for Blood Transfusion Will Fuel Market Growth

Target Audience of Blood Group Typing Market:

1. Manufacturers of blood group typing products
2. Vendors and distributors of blood group typing products
3. Hospitals and clinics
4. Blood banks
5. Research institutes
6. Venture capitalists and investors

Blood Group Typing Market, by Product & Service:

1. Consumables
2. Instruments
3. Services

Blood Group Typing Market, by Technique

1. PCR-based and Microarray Techniques
2. Assay-based Techniques
3. Massively Parallel Sequencing Techniques
4. Other Techniques

Blood Group Typing Market, by Test Type

1. Antibody Screening
2. HLA Typing
3. Cross-matching Tests
4. ABO Blood Tests
5. Antigen Typing

Key players in the Blood Group Typing Market include Bio-Rad Laboratories, Inc. (U.S.), Grifols, S.A. (Spain), Immucor, Inc. (U.S.), Ortho Clinical Diagnostics, Inc. (U.S.), Quotient, Ltd. (U.S.), Novacyt Group (France), BAG Healthcare GmbH (Germany), Rapid Labs (U.K.), Day medical SA (Switzerland), DIAGAST (France), and AXO Science (France).

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=72074095

Bio-Rad Laboratories, Inc. was the largest player in the market in 2015 with its strong product portfolio for blood group typing. The company focuses on acquisitions to strengthen its position in the market. For instance, in February 2015, Bio-Rad Laboratories acquired GnuBIO Inc. (U.S.). This acquisition helped the company to expand its blood group typing portfolio. Such acquisitions enabled the company to increase its product portfolio in the market. The company is also focused on expansion activities to increase its global presence.

The key strategies followed by most companies in the market are product launches and acquisitions.

What are the Global Growth Factors of Phototherapy Equipment Market?

 A number of factors, such as the rising incidence of neonatal jaundice across developed and developing markets, rising number of people suffering from skin diseases, inflow of technologically advanced products, and rising adoption of LED-based phototherapy equipment are driving the growth of Phototherapy Equipment Market.

What The Experts Says about the Market Growth?

The market is expected to reach $583.4 Million by 2021, at a CAGR of 4.5% from 2016 to 2021.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174360683 

Browse and in-depth TOC on "Phototherapy Equipment Market"

63 – Tables
41 - Figures
119 - Pages

Based on the type of equipment, the global phototherapy equipment market is divided into three segments, namely, conventional phototherapy equipment, LED phototherapy equipment, and fiberoptic phototherapy equipment. Based on the type of lamp installed in conventional phototherapy equipment, they are further segmented into equipment with fluorescent lamps and equipment with compact fluorescent lamps. Conventional phototherapy equipment with fluorescent lamps come in two different sizes, namely, full body phototherapy equipment and partial body phototherapy equipment.

On the basis of applications, the global phototherapy equipment market is segmented into skin disease treatment and neonatal jaundice treatment. The skin disease treatment segment is further divided into psoriasis treatment, vitiligo treatment, eczema treatment, and other disease treatment. On the basis of end user, the global phototherapy equipment industry is segmented into hospitals & clinics and home users.

Geographical Analysis:

North America held the largest share of the global phototherapy equipment market, followed by Europe. However, the Asia-Pacific market is expected to register the highest CAGR of 6.1% from 2016 to 2021. Factors such as strategic expansions by key market players in emerging Asian countries; growing adoption of low cost phototherapy equipment in India and China; and rising number of people suffering from skin diseases are responsible for the growth of the phototherapy equipment market in the Asia-Pacific region.

Get Expert Analysis and Insights of Global Market | Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=174360683

Key Market Players:

GE Healthcare (U.K.), Philips Lighting Holding B.V. (Netherlands), Natus Medical Incorporated (U.S.), Phoenix Medical Systems Pvt. Ltd. (India), Herbert Waldmann GmbH & Co. KG (Germany), Atom Medical Corporation (Japan), nice Neotech Medical Systems Pvt. Ltd. (India), National Biological Corp. (U.S.), and Solarc Systems Inc. (Canada) are some of the key players operating in the global phototherapy equipment market.

GE is one of the key global manufacturers of phototherapy equipment products. It sells its phototherapy equipment under the fetal and neonatal care segment. In order to sustain its leadership and ensure its future growth, the company has focused on both organic (new product launches and expansion) and inorganic growth strategies (such as collaboration and agreements).

By pursuing collaboration and agreements, the company has increased its customer base and sales & distribution networks across major markets. For example, in 2013, GE Healthcare signed an agreement with HealthTrust (U.S.) and collaborated with Perkumpulan Obstetri dan Ginekologi Indonesia (POGI, Indonesia). Furthermore, the company also focuses on strengthening its market presence in high-growth regions such as in Asia and Africa to compensate for revenue losses incurred in developed markets (such as the U.S. and Europe)

What is the future growth analysis of global Downstream Processing Market?

The global downstream processing market is poised to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4%

What are key factors driving growth of global Downstream Processing Market?

The growth of this market is propelled by the increasing demand for biopharmaceuticals and increasing R&D expenditure in the biopharmaceutical industry. Emerging markets such as Asia-Pacific provide new growth opportunities to players in the market. 

What the growth opportunities are in Downstream Processing Market?

1. Untapped Emerging Markets
2. Patent Expiry

Know more, Download PDF Brochure Now:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=73180930

Global Market Segmentation:

In the current market scenario, there is a growing demand for downstream processing. The market has been categorized based on the technique, product, application, end user, and region.

On the basis of product, the downstream processing market is classified into chromatography columns and resins, filters, membrane adsorbers, single-use products, and other products. In 2016, the chromatography columns and resins segment accounted for the largest share of the market. The constant need for newer and different types of columns and resins is likely to fuel market growth.

Based on technique, the market is segmented into purification, solid-liquid separation, and clarification/concentration. In 2016, the purification segment accounted for the largest share of the market. This high growth is attributed to the need for highly pure biopharmaceutical products to meet the regulatory standards, as downstream purification plays a significant role in enhancing the purity and quality of products aiding the growth of the purification market.

Based on application, the downstream processing market is categorized into monoclonal antibody (mAbs) production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and other applications. In 2016, the vaccine production segment accounted for the largest share of the market. Technological advancement in the downstream purification technology to develop high-quality products such as Vaccines at lower costs is expected to drive the growth of this segment.

Based on end user, the market is segmented into biopharmaceutical manufacturers and contract manufacturing organizations (CMOs). In 2016, the biopharmaceutical manufacturers segment accounted for the largest share of the market. The increasing demand for biopharmaceuticals among the aging population is expected to accelerate the growth of the biopharmaceutical manufacturers’ end-user segment.

Geographic Growth Analysis:

The growth of this market is propelled by the increasing demand for biopharmaceuticals and increasing R&D expenditure in the biopharmaceutical industry. Emerging markets such as Asia-Pacific provide new growth opportunities to players in the market. On the other hand, the high cost of instruments and the need for skilled professionals are expected to restrain the growth of this market to a certain extent during the forecast period. In addition, purification bottleneck, lack of single-use options, and dearth of skilled professionals are the major challenges in the downstream processing market

Get Your Queries Resolved From Subject Expert | Speak To Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=73180930

Key Players In Global Downstream Processing Market:

The market is dominated by established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.).